Pharmaceutical

STAT+: DOJ investigating Community Health Systems’ hosp...

Community Health Systems is facing a new federal probe into its hospital billing...

Colorado could cap payments for Amgen’s Enbrel

Colorado could be the first state to bring action against a drug maker via a sta...

Florida policy set amid measles outbreak alarms vaccina...

A Florida state policy set amid a measles outbreak in Broward County has vaccina...

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute w...

STAT+: Oregon suspends a portion of its drug transparen...

In a victory for the pharmaceutical industry, Oregon officials have suspended a ...

STAT+: Amgen’s rheumatoid arthritis drug Enbrel targete...

Colorado moves to cap the price of Etanercept, an autoimmune drug sold by Amgen ...

STAT+: UnitedHealth cyberattack impedes pharmacies’ and...

Hospitals and pharmacies are stuck in an insurance processing logjam after a cyb...

MHRA revokes Novartis’ Adakveo authorisation for sickle...

The UK MHRA has revoked a conditional marketing authorisation for Novartis' Adak...

Ono Pharmaceutical partners with EME for antibody drug ...

Ono Pharmaceutical has partnered with EME to advance the drug discovery of VHH a...

Telehealth abortion is an “effective, safe” tool for eq...

US patients are travelling to avoid abortion bans, but a new study has found tel...

Charles River and Wheeler Bio partner on therapeutic di...

Charles River has entered into a partnership with Wheeler Bio to expedite the pr...

FDA accepts Regeneron’s BLA for linvoseltamab for review

The FDA has accepted Regeneron’s biologics licence application (BLA) for linvose...

Digital transformation of the supply chain will make da...

One common factor can help make supply chains more comprehensible, resilient and...

Immunocore and BMS partner to investigate first-line tr...

The company will evaluate an IMC-F106C/Opdivo combination treatment in a Phase I...

Harmony wins orphan drug tag for pitolisant to treat Pr...

Harmony is advancing pitolisant into a Phase III clinical trial that is expected...

Immune-Onc’s antibody therapy collects second FDA orpha...

The company’s monoclonal antibody therapy, IO-202, has received its second orpha...